No abstract

Introduction: This review gives an overview of interesting properties of nanoparticles finding potential applications in nanomedicines and their considerations that need to be made such as toxicity while developing a nanomedicine by providing an understanding of a relationship between nanocarrier, targeting moieties and drugs with optical and magnetic properties. Here, we correlate the interesting properties of nanomaterials to their applications in living cells/body simultaneously promises, prospects and toxicity challenges of nanomedicines have also been discussed in detail. Exemplifying the usage of gold nanoparticles and its derivatives such as hetero and homo hybrid nanostructures that allow their use as contrast agents, therapeutic entities and supports to attach functional molecules and targeting ligand along with molecular framework structures. Here, we present the future prospects for potential applications in nanomedicines. These nanomaterials have been used for varieties of biomedical applications such as targeted drug delivery, photothermal cancer therapies, MRI, optical imaging, etc. in vitro and in vivo. Conclusion: In summary, this review provides innumerable aspects in the emerging field of nanomedicine and possible nanotoxicity.

No abstract

A facile solution‐based one‐step synthetic approach has been employed for an easy introduction of Nitrogen (N) into SnO2 lattice under the mild condition for a cocatalyst free hydrogen generation by photocatalytic water splitting. The crystal structure and morphology of synthesized N doped SnO2 nanoparticles were confirmed by powder X‐ray diffraction and electron microscopic techniques. Analysis by X‐ray Photoelectron Spectroscopy confirms that 4.6 % N was present in SnO2 lattice, while broadband observed in the Raman spectrum reveals the presence of oxygen vacancies and disordered structure due to N‐doping. The nanoparticles exhibit high surface area (139.7 m2/g) and bandgap close to 3.45 eV as deduced from Brunauer‐Emmett‐Teller (BET) measurement and Diffuse reflectance spectroscopic technique, respectively. The photocatalytic performance of the nanoparticles was evaluated by water splitting reaction for hydrogen generation using a photochemical reactor consisting of a Xenon lamp and was performed using different scavengers. It was found that out of various scavengers, maximum hydrogen yield, i. e., 169 μmol/g was achieved by N doped SnO2 nanoparticles with methanol and the order of scavengers for hydrogen generation using N doped SnO2 nanoparticles is Methanol>EDTA>TEOA.

No abstract

No abstract

No abstract

Over decades dependency of humans on the drugs has become indispensable and irreplaceable. Thus, each year many new drugs are licensed. Nonetheless, drugs undergo rigorous testing and analysis to be available globally in economic price for the suitability of patients with different age and physiological conditions. The testing of drugs include phase I clinical trial using small group of 20–100 healthy volunteers for safety, pharmacology and efficacy; phase II clinical trial using 100–500 volunteer patients to optimize effective dose, dose interval, safety analysis and mode of delivery such as oral or intravenous; phase III clinical trial using 1000–5000 in a larger population of patients globally at different international places to collect sufficient safety and efficacy data for patenting and licencing. Moreover, thousands of drugs fail to achieve these objectives. Therefore, this mini-review intends to critically examine and assimilate the clinical applications of selected complex repurposed small drug molecules which are in different phase of trials for treating viral infection including complications due to COVID-19: (a) Remdesivir, (b) Galidesivir, (c) Favipiravir, (d) Baricitinib, and (e) Baloxavir.